Gene · 2175
Papers3,803
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 3,803
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A novel DNA damage repair gene-related prognostic model for evaluating the prognosis and tumor microenvironment infiltration of esophageal squamous cell carcinoma. | BMC Med Genomics | 2023 | 36803971 | PubTator, text mining | PubMed |
| Human hematopoietic stem cell vulnerability to ferroptosis. | Cell | 2023 | 36803603 | PubTator, text mining | PubMed |
| Time for a paradigm shift in shared decision-making in trauma and emergency surgery? Results from an international survey. | World J Emerg Surg | 2023 | 36803568 | PubTator, text mining | PubMed |
| Genomic Biomarkers Associated with Response to Induction Chemotherapy in Patients with Localized Pancreatic Ductal Adenocarcinoma. | Clin Cancer Res | 2023 | 36795432 | PubTator, text mining | PubMed |
| DNA repair deficiency as circulating biomarker in prostate cancer. | Front Oncol | 2023 | 36793600 | PubTator, text mining | PubMed |
| Suppression of GCH1 Sensitizes Ovarian Cancer and Breast Cancer to PARP Inhibitor. | J Oncol | 2023 | 36793373 | PubTator, text mining | PubMed |
| Association of Reported Candidate Monogenic Genes With Lung Cancer Risk. | Clin Lung Cancer | 2023 | 36781323 | PubTator, text mining | PubMed |
| Unravelling homologous recombination repair deficiency and therapeutic opportunities in soft tissue and bone sarcoma. | EMBO Mol Med | 2023 | 36779660 | PubTator, text mining | PubMed |
| Utility of Comprehensive Genomic Profiling Tests for Patients with Incurable Pancreatic Cancer in Clinical Practice. | Cancers (Basel) | 2023 | 36765927 | PubTator, text mining | PubMed |
| Predictors of residual disease after debulking surgery in advanced stage ovarian cancer. | Front Oncol | 2023 | 36761962 | PubTator, text mining | PubMed |
| Therapeutic Targeting of DNA Damage Repair in the Era of Precision Oncology and Immune Checkpoint Inhibitors. | J Immunother Precis Oncol | 2023 | 36751656 | PubTator, text mining | PubMed |
| The pan-cancer analysis identified DIAPH3 as a diagnostic biomarker of clinical cancer. | Aging (Albany NY) | 2023 | 36750200 | PubTator, text mining | PubMed |
| Homologous recombination inquiry through ovarian malignancy investigations: JGOG3025 Study. | Cancer Sci | 2023 | 36747324 | PubTator, text mining | PubMed |
| Germline Cancer Gene Expression Quantitative Trait Loci Are Associated with Local and Global Tumor Mutations. | Cancer Res | 2023 | 36745477 | PubTator, text mining | PubMed |
| Advanced ovarian clear cell carcinoma with RAD50 mutation treated by PARP inhibitor pamiparib combined with anti-angiogenesis therapy: a case report. | Anticancer Drugs | 2023 | 36729997 | PubTator, text mining | PubMed |
| Exploring Subtypes of Repetitive Behavior in Children with Autism Through Functional Analysis and Wearable Technology: a Pilot Biobehavioral Assessment. | Adv Neurodev Disord | 2023 | 36721856 | PubTator, text mining | PubMed |
| Multilayer Heterogeneous Membrane Biosensor Based on Multiphysical Field Coupling for Human Serum Albumin Detection. | ACS Omega | 2023 | 36713688 | PubTator, text mining | PubMed |
| The effects of altered DNA damage repair genes on mutational processes and immune cell infiltration in esophageal squamous cell carcinoma. | Cancer Med | 2023 | 36708047 | PubTator, text mining | PubMed |
| Phase I Study and Cell-Free DNA Analysis of T-DM1 and Metronomic Temozolomide for Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases. | Clin Cancer Res | 2023 | 36705597 | PubTator, text mining | PubMed |
| A novel RAD51 variant resulting in Fanconi anemia identified in an infant with multiple congenital anomalies. | Clin Case Rep | 2023 | 36698515 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2175/papers?page=29